We claim to be doing pretty good in the area of health care and pharmaceuticals but still we haven't been able to come up with a formidable solution for the Nipah virus. Why ? Does this indicate that our pharmaceutical industry and pharmaceutical research organisations are inept at anything other than copying and pasting or is the solution really very complicated ?

More Biswajit Debnath's questions See All
Similar questions and discussions